Business Context and Reporting Period
This Form 6-K filing by Vantage Corp (Singapore) covers the month of June 2025. The report details the completion of the Company's Initial Public Offering (IPO) on June 13, 2025, following the effectiveness of its registration statement on Form F-1 on June 11, 2025. The Class A Ordinary Shares commenced trading on the NYSE American under the ticker symbol "VNTG" on June 12, 2025.
Key Financial Metrics
The filing focuses on capital raising activities rather than operational financial performance. Key metrics include:
- Gross Proceeds: $13,000,000 generated from the sale of 3,250,000 Class A Ordinary Shares at $4.00 per share.
- Over-Allotment Option: Underwriters were granted a 45-day option to purchase up to 487,500 additional shares.
- Warrants Issued: 162,500 warrants issued to the Representative and affiliates, exercisable at $5.00 per share, expiring five years from the commencement of sales.
- Operating Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the Company's transition to a publicly traded entity. Prior to June 13, 2025, the Company was a private issuer. The IPO represents a significant increase in equity capital and public market exposure. No comparative period financial data is provided in this filing to assess changes in operational performance.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future outlook, or a detailed discussion of risks and contingencies beyond standard legal disclaimers. The document notes that the report does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful. The summary of the Underwriting Agreement and Warrants is qualified by the full text of the attached exhibits.
Investor Verification Checklist
- Verify the final number of shares sold, including any exercise of the 45-day over-allotment option.
- Review the full Underwriting Agreement (Exhibit 10.1) for specific underwriting discounts and fees not detailed in the summary.
- Examine the Representative's Warrants (Exhibit 4.1) for specific exercise conditions and potential dilution effects.
- Confirm the Company's post-IPO cash position and use of proceeds by reviewing the audited financial statements in the Form F-1 Registration Statement.
- Monitor the trading volume and price stability of "VNTG" on the NYSE American following the June 12, 2025 listing.